<SEC-DOCUMENT>0001193125-16-505260-index.html : 20160315 <SEC-HEADER>0001193125-16-505260.hdr.sgml : 20160315 <ACCEPTANCE-DATETIME>20160315164006 ACCESSION NUMBER: 0001193125-16-505260 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20160315 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160315 DATE AS OF CHANGE: 20160315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 161507417 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 </SEC-HEADER> <DOCUMENT> <TYPE>8-K/A <SEQUENCE>1 <FILENAME>d159366d8ka.htm <DESCRIPTION>8-K/A <TEXT> Document 1 - file: d159366d8ka.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>d159366dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: d159366dex991.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>g159366g0315121937565.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: g159366g0315121937565.jpg
</DOCUMENT> </SEC-DOCUMENT>